Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.
| Autor: | Archer DF, Pinkerton JV, Guico-Pabia CJ, Hwang E, Cheng RF, Study 3353 Investigators, Archer, David F, Pinkerton, Joann V, Guico-Pabia, Christine J, Hwang, Eunhee, Cheng, Ru-Fong J |
|---|---|
| Zdroj: | Menopause (10723714); 2013 Jan, Vol. 20 Issue 1, p47-56, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|